H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 92 Citations 33,714 465 World Ranking 5463 National Ranking 514

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Stroke
  • Surgery

Philip M.W. Bath mostly deals with Stroke, Internal medicine, Surgery, Anesthesia and Randomized controlled trial. The concepts of his Stroke study are interwoven with issues in Physical therapy, Vascular disease, Blood pressure and Clinical trial. He interconnects Endocrinology and Cardiology in the investigation of issues within Internal medicine.

His Surgery research includes themes of Systematic review, Hyperintensity and Telmisartan. His Anesthesia study combines topics in areas such as Granulocyte colony-stimulating factor, Brain ischemia, Ischemia, Nitric oxide and Aspirin. The Randomized controlled trial study combines topics in areas such as Psychiatry, Intracerebral hemorrhage, Tinzaparin sodium and Intensive care medicine.

His most cited work include:

  • Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 (1793 citations)
  • Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial (805 citations)
  • Blood Pressure and Clinical Outcomes in the International Stroke Trial (713 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Stroke, Internal medicine, Cardiology, Randomized controlled trial and Blood pressure. His Stroke study integrates concerns from other disciplines, such as Anesthesia, Physical therapy, Clinical trial and Surgery. He regularly ties together related areas like Endocrinology in his Internal medicine studies.

His Cardiology research incorporates elements of Candesartan, Platelet, Ischaemic stroke and Ischemic stroke. His studies deal with areas such as Adverse effect and Intracerebral hemorrhage as well as Randomized controlled trial. His work carried out in the field of Blood pressure brings together such families of science as Hemodynamics, Cerebral blood flow, Nitric oxide and Thrombolysis.

He most often published in these fields:

  • Stroke (69.68%)
  • Internal medicine (51.42%)
  • Cardiology (28.81%)

What were the highlights of his more recent work (between 2018-2021)?

  • Stroke (69.68%)
  • Internal medicine (51.42%)
  • Cardiology (28.81%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Stroke, Internal medicine, Cardiology, Randomized controlled trial and Anesthesia. Philip M.W. Bath studies Modified Rankin Scale which is a part of Stroke. His Lacunar stroke, Clopidogrel, Cilostazol and Case fatality rate study in the realm of Internal medicine connects with subjects such as In patient.

His Cardiology study incorporates themes from Acute ischemic stroke, Ischemic stroke, Ischaemic stroke, Disease and Acute stroke. Philip M.W. Bath works mostly in the field of Randomized controlled trial, limiting it down to topics relating to Platelet transfusion and, in certain cases, Anticoagulant. His Anesthesia research is multidisciplinary, incorporating elements of Intracerebral hemorrhage, Incidence, Stimulation, Transdermal glyceryl trinitrate and Neurology.

Between 2018 and 2021, his most popular works were:

  • Vascular dysfunction-The disregarded partner of Alzheimer's disease (175 citations)
  • Vascular dysfunction-The disregarded partner of Alzheimer's disease (175 citations)
  • Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial (73 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Stroke
  • Surgery

Philip M.W. Bath spends much of his time researching Stroke, Randomized controlled trial, Internal medicine, Cardiology and Anesthesia. His Stroke research includes elements of Adverse effect, Confidence interval, Meta-analysis, Emergency medicine and Dysphagia. His research in Randomized controlled trial intersects with topics in Odds ratio, Thrombolysis, Clinical trial and Modified Rankin Scale.

His biological study deals with issues like Lacunar stroke, which deal with fields such as Disease. He combines subjects such as Stimulation, Pharynx and Blood pressure with his study of Anesthesia. Philip M.W. Bath focuses mostly in the field of Aspirin, narrowing it down to matters related to Dipyridamole and, in some cases, Myocardial infarction.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Guidelines for management of ischaemic stroke and transient ischaemic attack 2008

Peter A. Ringleb;Marie Germaine Bousser;Gary Ford;Philip Bath.
Cerebrovascular Diseases (2008)

2884 Citations

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

Ralph L. Sacco;Hans-Christoph Diener;Salim Yusuf;Daniel Cotton.
The New England Journal of Medicine (2008)

1117 Citations

Platelet size: measurement, physiology and vascular disease

P. M. W. Bath;R. J. Butterworth.
Blood Coagulation & Fibrinolysis (1996)

1077 Citations

Blood Pressure and Clinical Outcomes in the International Stroke Trial

Jo Leonardi-Bee;Philip M.W. Bath;Stephen J. Phillips;Peter A.G. Sandercock.
Stroke (2002)

990 Citations

Telmisartan to prevent recurrent stroke and cardiovascular events.

Salim Yusuf;Hans-Christoph Diener;Ralph L. Sacco;Daniel Cotton.
The New England Journal of Medicine (2008)

930 Citations

Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events A Systematic Review

Parveen Rashid;Jo Leonardi-Bee;Philip Bath.
Stroke (2003)

895 Citations

Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

J O'Brien;H Duncan;G Kirsh;V Allen.
The Lancet (2000)

805 Citations

High Blood Pressure in Acute Stroke and Subsequent Outcome. A Systematic Review

Mark Willmot;Jo Leonardi-Bee;Philip M.W. Bath.
Hypertension (2004)

794 Citations

Influence of platelet size on outcome after myocardial infarction

J. F. Martin;P. Bath;Michael Leslie Burr.
The Lancet (1991)

710 Citations

The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial

Else Charlotte Sandset;Else Charlotte Sandset;Philip M. W. Bath;Gudrun Boysen;Dalius Jatuzis.
The Lancet (2011)

543 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Philip M.W. Bath

Craig S. Anderson

Craig S. Anderson

George Institute for Global Health

Publications: 144

Malcolm R. Macleod

Malcolm R. Macleod

University of Edinburgh

Publications: 105

Kennedy R. Lees

Kennedy R. Lees

University of Glasgow

Publications: 104

John Chalmers

John Chalmers

George Institute for Global Health

Publications: 73

Hans-Christoph Diener

Hans-Christoph Diener

University of Duisburg-Essen

Publications: 72

Joanna M. Wardlaw

Joanna M. Wardlaw

University of Edinburgh

Publications: 71

Bruce Ovbiagele

Bruce Ovbiagele

University of California, San Francisco

Publications: 68

Jeffrey L Saver

Jeffrey L Saver

University of California, Los Angeles

Publications: 67

Peter M. Rothwell

Peter M. Rothwell

University of Oxford

Publications: 63

Gregory Y.H. Lip

Gregory Y.H. Lip

University of Liverpool

Publications: 62

Graeme J. Hankey

Graeme J. Hankey

University of Western Australia

Publications: 61

Werner Hacke

Werner Hacke

Heidelberg University

Publications: 56

Turgut Tatlisumak

Turgut Tatlisumak

University of Gothenburg

Publications: 56

Peter Sandercock

Peter Sandercock

University of Edinburgh

Publications: 50

Geoffrey A. Donnan

Geoffrey A. Donnan

Royal Melbourne Hospital

Publications: 49

Ashfaq Shuaib

Ashfaq Shuaib

University of Alberta

Publications: 48

Something went wrong. Please try again later.